JnJ gets USFDA breakthrough therapy designation for TAR 200 for bladder cancer treatment Ruchika Sharma5 Dec 2023 11:27 AM ISTTAR-200 is a novel investigational targeted releasing system designed to provide sustained local release of gemcitabine into the bladder.
JnJ appoints Eugene A Woods to its Board of Directors Ruchika Sharma3 Dec 2023 12:45 PM ISTNew Brunswick: Johnson & Johnson has announced that Eugene A. Woods, MBA, MHA, Chief Executive Officer of Advocate Health, has been appointed...
Johnson & Johnson MedTech buys Laminar for USD 400 million Ruchika Sharma3 Dec 2023 12:30 PM ISTNew Brunswick: Johnson & Johnson MedTech has announced the completion of the acquisition of Laminar, Inc., a privately-held medical device...
Turkey launches investigation into 19 pharma cos Ruchika Sharma1 Dec 2023 12:49 PM ISTAnkara: Turkey's competition authority said on Thursday it had launched an investigation into 19 pharmaceutical companies to determine whether they...
Janssen seeks USFDA nod for Rybrevant plus chemotherapy for patients with EGFR-Mutated Non-Small Cell Lung Cancer who progressed on or after Osimertinib Ruchika Sharma23 Nov 2023 2:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License ...
Sanofi completes closing for potential vaccine against extraintestinal pathogenic E.coli Ruchika Sharma12 Nov 2023 5:00 PM ISTParis: Sanofi has announced the completion of closing for its collaborative agreement with Janssen Pharmaceuticals, Inc., a Johnson & Johnson...
Sanofi considers listing consumer unit late next year Ruchika Sharma30 Oct 2023 2:30 PM ISTNew Delhi: Sanofi has mapped out a separate listing of its consumer healthcare business from the fourth quarter of next year, the French drugmaker...
Johnson and Johnson faces 18 talc cancer trials, prompting it again to consider bankruptcy Roshni Dhar30 Oct 2023 2:25 PM ISTJohnson & Johnson faces at least 18 jury trials over the next year tied to claims of tainted talc in its iconic baby powder, prompting the company...
Health Bulletin 28/October/2023 Roshni Dhar28 Oct 2023 4:46 PM ISTHere are the top health stories for the day:JnJ faces 18 talc cancer trials, prompting it again to consider bankruptcyJohnson & Johnson faces at...
JnJ faces 18 talc cancer trials, prompting it again to consider bankruptcy Ruchika Sharma27 Oct 2023 5:25 PM ISTJohnson & Johnson faces at least 18 jury trials over the next year tied to claims of tainted talc in its iconic baby powder, prompting the company...
JnJ names Tim Schmid as Executive Vice President, Worldwide Chairman of MedTech Ruchika Sharma25 Oct 2023 1:30 PM ISTNew Brunswick: Johnson & Johnson has announced that Ashley McEvoy, Executive Vice President, Worldwide Chairman of MedTech, informed the...
First pill for dengue shows promise in human challenge trial Roshni Dhar23 Oct 2023 3:30 PM ISTA pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human...
